David B. Huang

H. Dupont, David N. Taylor, P. Okhuysen, 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Enteroaggregative Escherichia coli: an emerging pathogen in children.

H. Dupont, David B. Huang, 2004, Seminars in pediatric infectious diseases.

United States male students who heavily consume alcohol in Mexico are at greater risk of travelers' diarrhea than their female counterparts.

H. Dupont, Zhi-Dong Jiang, C. Ericsson, 2006, Journal of travel medicine.

The prevalence and virulence characteristics of enteroaggregative Escherichia coli at an urgent-care clinic in the USA: a case-control study.

Atif Abbas, David B. Huang, T. Chiang, 2009, Journal of medical microbiology.

Virulence characteristics and the molecular epidemiology of enteroaggregative Escherichia coli isolates from travellers to developing countries.

H. Dupont, J. Nataro, P. Okhuysen, 2007, Journal of medical microbiology.

Interleukin-8 Response in an Intestinal HCT-8 Cell Line Infected with Enteroaggregative and Enterotoxigenic Escherichia coli

H. Dupont, P. Okhuysen, Zhi-Dong Jiang, 2004, Clinical Diagnostic Laboratory Immunology.

Enteroaggregative Escherichia coli: An emerging pathogen

H. Dupont, David B. Huang, H. Koo, 2004, Current infectious disease reports.

Enteroaggregative Escherichia coli: An Emerging Enteric Pathogen

H. Dupont, P. Okhuysen, Zhi-Dong Jiang, 2004, American Journal of Gastroenterology.

Bacteremia Caused by Acinetobacter baumannii: Epidemiologic Features, Antimicrobial Susceptibility, and Outcomes

M. Pastagia, David B. Huang, T. Chiang, 2014 .

Resiquimod: a new immune response modifier with potential as a vaccine adjuvant for Th1 immune responses.

S. Tyring, Jashin J. Wu, David B. Huang, 2004, Antiviral research.

The role of diabetes mellitus in the treatment of skin and skin structure infections caused by methicillin-resistant Staphylococcus aureus: results from three randomized controlled trials.

K. Itani, Benjamin A Lipsky, J. Weigelt, 2011, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Association of virulence factor-positive and -negative enteroaggregative Escherichia coli and occurrence of clinical illness in travelers from the United States to Mexico.

H. Dupont, Zhi-Dong Jiang, David B. Huang, 2003, The American journal of tropical medicine and hygiene.

Chapter 23 – Rickettsial infections

S. Tyring, Jashin J. Wu, David B. Huang, 2006 .

Combined retrospective analysis of seven phase II and III trials of the efficacy of linezolid in the treatment of pneumonia caused by multidrug-resistant Streptococcus pneumoniae.

K. Tack, David B. Huang, M. Ijzerman, 2010, Clinical therapeutics.

Effect of intensive handwashing in the prevention of diarrhoeal illness among patients with AIDS: a randomized controlled study.

David B. Huang, Jingyan Zhou, 2007, Journal of medical microbiology.

Potential for Cost Saving with Iclaprim Owing to Avoidance of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections

David B. Huang, N. Patel, T. Lodise, 2018, Clinical Drug Investigation.

Rifaximin Therapy of Irritable Bowel Syndrome

H. Dupont, David B. Huang, H. Koo, 2012, Clinical medicine insights. Gastroenterology.

Effect of Vancomycin-Associated Acute Kidney Injury on Incidence of 30-Day Readmissions among Hospitalized Veterans Affairs Patients with Skin and Skin Structure Infections

David B. Huang, N. Patel, T. Lodise, 2020, Antimicrobial Agents and Chemotherapy.

Linezolid effects on bacterial toxin production and host immune response: review of the evidence.

B. Diep, O. Equils, R. Gladue, 2012, Current therapeutic research, clinical and experimental.

Rickettsial Infections Around the World, Part 1: Pathophysiology and the Spotted Fever Group

S. Tyring, Jashin J. Wu, David B. Huang, 2005, Journal of cutaneous medicine and surgery.

The Impact of Linezolid and Vancomycin Treatment on Local Signs and Symptoms of Inflammation Among Pediatric Patients With Complicated Skin and Skin Structure Infections

O. Equils, David B. Huang, J. Deville, 2011, Clinical pediatrics.

K2 Serotype Klebsiella pneumoniae Causing a Liver Abscess Associated with Infective Endocarditis

D. Alland, David B. Huang, T. Chiang, 2009, Journal of Clinical Microbiology.

Subcutaneous fungal infections

Jashin J. Wu, David B. Huang, K. R. Pang, 2004, Dermatologic therapy.

Common Respiratory Viruses and Pulmonary Mucosal Immunology

David B. Huang, 2006, Mucosal Immunology and Virology.

Prosthetic Joint Infection due to Mycobacterium bovis after Intravesical Instillation of Bacillus Calmette-Guerin (BCG)

R. Eng, David B. Huang, T. Chiang, 2009, International journal of microbiology.

An updated review on Cryptosporidium and Giardia.

A. White, David B. Huang, A. White, 2006, Gastroenterology clinics of North America.

Biofilm formation by enterococci.

David B. Huang, Jamal A. Mohamed, 2007, Journal of medical microbiology.

Therapy of common superficial fungal infections

S. Tyring, Jashin J. Wu, L. Ostrosky-Zeichner, 2004, Dermatologic therapy.

Advances in antiviral therapy.

S. Tyring, Jashin J. Wu, David B. Huang, 2005, Dermatologic clinics.

Frontiers in Clinical Drug Research-Anti Infectives

J. Hauber, Xiaochen Bo, M. Hornef, 2017 .

Problem pathogens: extra-intestinal complications of Salmonella enterica serotype Typhi infection.

H. Dupont, David B. Huang, 2005, The Lancet. Infectious diseases.

A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines

S. Tyring, Jashin J. Wu, David B. Huang, 2004, Journal of Infection.

Vaccines and immunotherapies for the prevention of infectious diseases having cutaneous manifestations.

S. Tyring, Jashin J. Wu, David B. Huang, 2004, Journal of the American Academy of Dermatology.

Cryptosporidiosis in children.

P. Okhuysen, C. Chappell, David B. Huang, 2004, Seminars in pediatric infectious diseases.

A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections

M. Veve, M. Rybak, S. Davis, 2020, Infectious Diseases and Therapy.

A review of an emerging enteric pathogen: enteroaggregative Escherichia coli.

H. Dupont, P. Okhuysen, David B. Huang, 2006, Journal of medical microbiology.

Antibody Response of Healthy Adults to Recombinant Thrombospondin-Related Adhesive Protein of Cryptosporidium 1 after Experimental Exposure to Cryptosporidium Oocysts

S. Tzipori, A. Crisanti, P. Okhuysen, 2004, Clinical Diagnostic Laboratory Immunology.

Association of Putative Enteroaggregative Escherichia coli Virulence Genes and Biofilm Production in Isolates from Travelers to Developing Countries

H. Dupont, J. Nataro, P. Okhuysen, 2006, Journal of Clinical Microbiology.

A Phase 3, Randomized, Double-Blind, Multicenter Study To Evaluate the Safety and Efficacy of Intravenous Iclaprim versus Vancomycin for Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed To Be Due to Gram-Positive Pathogens (REVIVE-2 Study)

T. File, A. Torres, M. Wilcox, 2018, Antimicrobial Agents and Chemotherapy.

A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens: REVIVE-1

T. File, A. Torres, M. Wilcox, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Phase II Randomized, Double-blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Confirmed to be Due to Gram-positive Pathogens.

T. File, P. Hadváry, A. Shorr, 2017, Clinical therapeutics.

Biological and Clinical Basis for Molecular Studies of Interferons

S. Baron, S. Tyring, Jashin J. Wu, 2005, Methods in molecular medicine.

Rickettsial Infections Around the World, Part 2: Rickettsialpox, the Typhus Group, and Bioterrorism

S. Tyring, Jashin J. Wu, David B. Huang, 2005, Journal of cutaneous medicine and surgery.

Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.

J. Barreto, L. Morrow, L. Puzniak, 2013, Clinical therapeutics.

Reactive Hemophagocytosis Associated with the Initiation of Highly Active Antiretroviral Therapy (HAART) in a Patient with AIDS

Jashin J. Wu, R. Hamill, David B. Huang, 2004, Scandinavian journal of infectious diseases.

Combination Therapy With Lysin CF-301 and Antibiotic Is Superior to Antibiotic Alone for Treating Methicillin-Resistant Staphylococcus aureus–Induced Murine Bacteremia

M. Wittekind, V. Fischetti, R. Nowinski, 2013, The Journal of infectious diseases.

The role of rifaximin in the treatment and chemoprophylaxis of travelers’ diarrhea

H. Dupont, David B. Huang, H. Koo, 2009, Therapeutics and clinical risk management.

Postherpetic poliosis.

S. Tyring, Jashin J. Wu, David B. Huang, 2006, Archives of dermatology.

Efficacy of Antistaphylococcal Lysin LSVT-1701 in Combination with Daptomycin in Experimental Left-Sided Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus

K. Borroto-Esoda, A. Bayer, Y. Xiong, 2021, Antimicrobial agents and chemotherapy.

Efficacy of Anti-Staphylococcal Lysin, LSVT-1701, in Combination with Daptomycin in Experimental Left-Sided Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus (MRSA)

K. Borroto-Esoda, A. Bayer, Y. Xiong, 2021, bioRxiv.

Enteroaggregative Escherichia coli is a cause of acute diarrheal illness: a meta-analysis.

H. Dupont, J. Nataro, P. Okhuysen, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Basics and the Advancements in Diagnosis of Bacterial Lower Respiratory Tract Infections

David B. Huang, S. Noviello, 2019, Diagnostics.

Pharmacokinetic and Pharmacodynamic Analyses To Determine the Optimal Fixed Dosing Regimen of Iclaprim for Treatment of Patients with Serious Infections Caused by Gram-Positive Pathogens

J. Bosso, David B. Huang, Paul J. Williams, 2017, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of Iclaprim against Methicillin-Resistant Staphylococcus aureus Nonsusceptible to Daptomycin, Linezolid, or Vancomycin: A Pilot Study

D. Sahm, S. Hawser, C. Gemmell, 2017, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

The effects of iclaprim on exotoxin production in methicillin‐resistant and vancomycin‐intermediate Staphylococcus aureus

D. Stevens, A. Bryant, David B. Huang, 2019, Journal of Medical Microbiology.

Worldwide surveillance of Iclaprim activity: In Vitro susceptibility of gram-positive pathogens collected from patients with skin and skin structure infections from 2013 to 2017.

C. Charrier, S. Hawser, David B. Huang, 2020, Diagnostic microbiology and infectious disease.

A Pooled Analysis of the Safety and Efficacy of Iclaprim Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Patients With Intravenous Drug Use: Phase 3 REVIVE Studies.

Amy Scaramucci, G. Corey, David B. Huang, 2019, Clinical therapeutics.

Surveillance of iclaprim activity: In vitro susceptibility of gram-positive pathogens collected from 2012 to 2014 from the United States, Asia Pacific, Latin American and Europe.

T. File, A. Torres, M. Wilcox, 2017, Diagnostic microbiology and infectious disease.

Erratum: A review of an emerging enteric pathogen: Enteroaggregative Escherichia coli (Journal of Medical Microbiology (2006) 55, 10 (1303-1311))

H. Dupont, P. Okhuysen, David B. Huang, 2007 .

Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections.

T. File, A. Torres, M. Wilcox, 2018, International journal of antimicrobial agents.

The activity of the diaminopyrimidine dihydrofolate reducatase inhibitor, iclaprim, against Toxoplasma gondii in an in vitro model: a pilot study.

David B. Huang, 2020, Diagnostic microbiology and infectious disease.

Phenotypic and genotypic screening and clonal analysis of carbapenem-resistant Klebsiella pneumoniae at a single hospital.

R. Eng, David B. Huang, C. Urban, 2011, Microbial drug resistance.

The use of linezolid in the treatment of paediatric patients with infections caused by enterococci including strains resistant to vancomycin.

S. Kaplan, O. Equils, J. Goldfarb, 2010, The Journal of antimicrobial chemotherapy.

Identification of carbapenem-resistant klebsiella pneumoniae harboring KPC enzymes in New Jersey.

R. Eng, David B. Huang, C. Urban, 2007, Microbial drug resistance.

Plasmid transferability of KPC into a virulent K2 serotype Klebsiella pneumoniae

L. K. Siu, David B. Huang, T. Chiang, 2014, BMC Infectious Diseases.

In vitro activity of dihydrofolate reductase inhibitors and other antibiotics against Gram-positive pathogens collected globally between 2004 and 2016.

S. Hawser, H. Sader, David B. Huang, 2019, Journal of global antimicrobial resistance.

Iclaprim activity against wild-type and corresponding thymidine kinase–deficient Staphylococcus aureus in a mouse protection model

Jee-Hyun Park, David B. Huang, Timothy M. Murphy, 2018, European Journal of Clinical Microbiology & Infectious Diseases.

Iclaprim, a dihydrofolate reductase inhibitor antibiotic in Phase III of clinical development: a review of its pharmacology, microbiology and clinical efficacy and safety.

M. Dryden, David B. Huang, 2018, Future microbiology.

Comparison of serotonin toxicity with concomitant use of either linezolid or comparators and serotonergic agents: an analysis of Phase III and IV randomized clinical trial data.

A. Reisman, David B. Huang, T. Lodise, 2012, The Journal of antimicrobial chemotherapy.

A Phase II Randomized , Double-blind , Multicenter Study to Evaluate Ef fi cacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Con fi rmed to be Due to Gram-positive Pathogens

T. File, P. Hadváry, A. Shorr, 2017 .

Efficacy Evaluation of Iclaprim in a Neutropenic Rat Lung Infection Model with Methicillin-Resistant Staphylococcus aureus Entrapped in Alginate Microspheres

I. Morrissey, S. Hawser, David B. Huang, 2017, European Journal of Clinical Microbiology & Infectious Diseases.

This is a repository copy of Efficacy evaluation of iclaprim in a neutropenic rat lung infection model with methicillin-resistant Staphylococcus aureus entrapped in alginate

I. Morrissey, M. Wilcox, S. Hawser, 2018 .

Toxic Epidermal Necrolysis as a Complication of Treatment with Voriconazole

Jashin J. Wu, David B. Huang, C. Lahart, 2004, Southern medical journal.

A pooled analysis of patients with wound infections in the Phase 3 REVIVE trials: randomized, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin structure infections.

T. File, A. Torres, M. Wilcox, 2020, Journal of medical microbiology.

Surveillance of iclaprim activity: in vitro susceptibility of Gram-positive skin infection pathogens collected from 2015 to 2016 from North America and Europe.

T. File, A. Torres, M. Wilcox, 2019, Diagnostic microbiology and infectious disease.

Methicillin-Resistant Staphylococcus aureus SCC mec Type and Its Association with Clinical Presentation, Severity, and Length of Stay among Patients with Complicated Skin and Skin Structure Infections

David B. Huang, P. Hogan, D. Myers, 2014 .

Clinical Outcomes by Methicillin-Resistant Staphylococcus aureus Staphylococcal Cassette Chromosome mec Type: Isolates Recovered from a Phase IV Clinical Trial of Linezolid and Vancomycin for Complicated Skin and Skin Structure Infections

A. Reisman, David B. Huang, P. Hogan, 2010, Antimicrobial Agents and Chemotherapy.

Emergence of trimethoprim-resistant Escherichia coli in healthy persons in the absence of prophylactic or therapeutic antibiotics during travel to Guadalajara, Mexico.

Z. Jiang, H. Dupont, Zhi-Dong Jiang, 2001, Scandinavian journal of infectious diseases.

Polymyxin Combination Therapy and the Use of Serum Bactericidal Titers in the Management of KPC-Producing Klebsiella pneumoniae Infections: A Report of 3 Cases

R. Eng, David B. Huang, C. Urban, 2011, Case reports in medicine.

Seroprevalence of the enteroaggregative Escherichia coli virulence factor dispersin among USA travellers to Cuernavaca, Mexico: a pilot study.

H. Dupont, J. Nataro, E. Brown, 2008, Journal of medical microbiology.

Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.

J. Barreto, L. Morrow, David B. Huang, 2013, Clinical therapeutics.

Characteristics, Treatment, and Outcomes Associated with Clostridium difficile Associated Diarrhea in a Veterans Affairs Medical Center

David B. Huang, T. Chiang, Han M. Lee, 2014 .